Category Archives: News

FDA to support FLUIDDA’s FRI technology in the quest for more affordable drugs

The US Food and Drug administration has issued a letter of support to FLUIDDA after examination of study results where Functional Respiratory Imaging was used to assess bio-equivalence between a generic and a reference drug. Manufacturers of generic drugs are required to demonstrate that their drugs are therapeutically equivalent to the reference drug before they… Continue Reading

UCSF and FLUIDDA enter into a new research collaboration

Los Angeles, January 5th 2018 FLUIDDA Inc and the University of California, San Francisco (UCSF) are entering into a new research collaboration as of December 2017. Together with the team of Dr. John Fahy (Professor of Medicine in the Division of Pulmonary and Critical Care Medicine, Department of Medicine and investigator in the Cardiovascular Research… Continue Reading

FLUIDDA opens office in Los Angeles, CA

The opening of an office in Los Angeles (West Hollywood), California, marks the further expansion of FLUIDDA’s global presence. With an increasing number of clients located at the US West Coast, the California office allows FLUIDDA to provide an even better customer experience. “The high concentration of pharmaceuticals and medical device companies, as well as… Continue Reading

SimInhale Symposium at DDL2017

Our COO Wim Vos had a very interesting discussion this morning on drug delivery into the lungs of children and infants. Can FLUIDDA‘s FRI be the tool to evaluate the performance of nebulized , DPI or soft mist delivery in this population? SimInhale #DDL2017 Continue Reading

Conference: Inhaled Drug Delivery – from 13 till 14 November in London

Conference: Inhaled Drug Delivery – from 13 till 14 November in London

Management Forum is currently having its 2-day annual conference inhaled drug development. Industry leaders are coming together on November 13 and 14 in London to discuss the current challenges, advancements and possibilities of current inhalation devices and technologies. A lot of attention is also going to the role of patients’ contribution to therapy in adequate… Continue Reading